Colesevelam Hydrochloride Patent Expiration
Colesevelam Hydrochloride is Used for lowering serum glucose levels in adults with type 2 diabetes mellitus and lowering cholesterol levels. It was first introduced by Cosette Pharmaceuticals Inc
Colesevelam Hydrochloride Patents
Given below is the list of patents protecting Colesevelam Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Welchol |
US7229613 (Pediatric) | Method for lowering serum glucose |
Oct 17, 2022
(Expired) | Cosette |
| Welchol | US7229613 | Method for lowering serum glucose |
Apr 17, 2022
(Expired) | Cosette |
| Welchol |
US5693675 (Pediatric) | Alkylated amine polymers |
Jun 02, 2015
(Expired) | Cosette |
| Welchol |
US5607669 (Pediatric) | Amine polymer sequestrant and method of cholesterol depletion |
Dec 10, 2014
(Expired) | Cosette |
| Welchol |
US5919832 (Pediatric) | Amine polymer sequestrant and method of cholesterol depletion |
Dec 10, 2014
(Expired) | Cosette |
| Welchol |
US6066678 (Pediatric) | Process for removing bile salts from a patient and alkylated compositions therefor |
Dec 10, 2014
(Expired) | Cosette |
| Welchol |
US6433026 (Pediatric) | Process for removing bile salts from a patient and alkylated compositions therefor |
Dec 10, 2014
(Expired) | Cosette |
| Welchol | US5693675 | Alkylated amine polymers |
Dec 02, 2014
(Expired) | Cosette |
| Welchol |
US5679717 (Pediatric) | Method for removing bile salts from a patient with alkylated amine polymers |
Oct 29, 2014
(Expired) | Cosette |
| Welchol |
US5917007 (Pediatric) | Process for removing bile salts from a patient and alkylated compositions therefor |
Oct 29, 2014
(Expired) | Cosette |
| Welchol |
US5919832 (Pediatric) | Amine polymer sequestrant and method of cholesterol depletion |
Oct 29, 2014
(Expired) | Cosette |
| Welchol |
US6066678 (Pediatric) | Process for removing bile salts from a patient and alkylated compositions therefor |
Oct 29, 2014
(Expired) | Cosette |
| Welchol |
US6433026 (Pediatric) | Process for removing bile salts from a patient and alkylated compositions therefor |
Oct 29, 2014
(Expired) | Cosette |
| Welchol |
US6784254 (Pediatric) | Process for removing bile salts from a patient and alkylated compositions therefor |
Oct 29, 2014
(Expired) | Cosette |
| Welchol |
US7101960 (Pediatric) | Process for removing bile salts from a patient and alkylated compositions therefor |
Oct 29, 2014
(Expired) | Cosette |
| Welchol | US5607669 | Amine polymer sequestrant and method of cholesterol depletion |
Jun 10, 2014
(Expired) | Cosette |
| Welchol | US5919832 | Amine polymer sequestrant and method of cholesterol depletion |
Jun 10, 2014
(Expired) | Cosette |
| Welchol | US6066678 | Process for removing bile salts from a patient and alkylated compositions therefor |
Jun 10, 2014
(Expired) | Cosette |
| Welchol | US6433026 | Process for removing bile salts from a patient and alkylated compositions therefor |
Jun 10, 2014
(Expired) | Cosette |
| Welchol | US5679717 | Method for removing bile salts from a patient with alkylated amine polymers |
Apr 29, 2014
(Expired) | Cosette |
| Welchol | US5917007 | Process for removing bile salts from a patient and alkylated compositions therefor |
Apr 29, 2014
(Expired) | Cosette |
| Welchol | US5919832 | Amine polymer sequestrant and method of cholesterol depletion |
Apr 29, 2014
(Expired) | Cosette |
| Welchol | US6066678 | Process for removing bile salts from a patient and alkylated compositions therefor |
Apr 29, 2014
(Expired) | Cosette |
| Welchol | US6433026 | Process for removing bile salts from a patient and alkylated compositions therefor |
Apr 29, 2014
(Expired) | Cosette |
| Welchol | US6784254 | Process for removing bile salts from a patient and alkylated compositions therefor |
Apr 29, 2014
(Expired) | Cosette |
| Welchol | US7101960 | Process for removing bile salts from a patient and alkylated compositions therefor |
Apr 29, 2014
(Expired) | Cosette |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Colesevelam Hydrochloride's patents.
Latest Legal Activities on Colesevelam Hydrochloride's Patents
Given below is the list recent legal activities going on the following patents of Colesevelam Hydrochloride.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 29 Nov, 2018 | US7229613 |
| Expire Patent Critical
| 08 Oct, 2018 | US7101960 |
| Maintenance Fee Reminder Mailed Critical
| 16 Apr, 2018 | US7101960 |
| Post Issue Communication - Certificate of Correction | 24 Apr, 2008 | US7101960 |
| PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED Critical
| 10 Mar, 2008 | US6784254 |
| Terminal Disclaimer Filed Critical
| 04 Feb, 2008 | US6784254 |
| Patent Issue Date Used in PTA Calculation Critical
| 12 Jun, 2007 | US7229613 |
| Recordation of Patent Grant Mailed Critical
| 12 Jun, 2007 | US7229613 |
| Issue Notification Mailed Critical
| 23 May, 2007 | US7229613 |
| Dispatch to FDC | 04 May, 2007 | US7229613 |
Colesevelam Hydrochloride's Family Patents
